New Standard Identified for Resection of Mid to Low Esophageal Cancers

The use of hybrid minimally invasive esophagectomy reduced postoperative morbidity in patients with esophageal cancers, according to the results of the MIRO trial (abstract 615O_PR) presented at the European Society for Medical Oncology (ESMO) 2017 Congress in Madrid.
http://www.cancernetwork.com/esophageal-cancer/new-standard-identified-resection-mid-low-esophageal-cancers

AUDIENCES

Caregivers
Friends and Family
General Public
Medical Profession
Patients
Survivors

SUBJECTS

Post Surgical

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino